Harvard Women's Health Watch

No need for routine ovarian cancer screening

Although ovarian cancer doesn't get as much media attention as breast cancer, it's the deadlier of the two diseases, causing more deaths than any other reproductive cancer in women.

Ovarian cancer is easiest to treat when it's caught early, but health organizations generally don't recommend routine screening for women who aren't at high risk.

In September, the U.S. Preventive Services Task Force (USPSTF) reaffirmed its 2004 recommendation that average-risk women not be routinely screened for ovarian cancer with a transvaginal ultrasound or CA-125 cancer marker blood test.

To continue reading this article, you must login.
  • Research health conditions
  • Check your symptoms
  • Prepare for a doctor's visit or test
  • Find the best treatments and procedures for you
  • Explore options for better nutrition and exercise
Learn more about the many benefits and features of joining Harvard Health Online »